Aehr Test Systems: The FY2027 Rebound Is Real, But The Price Asks For Too Much (AEHR)

This article was written by Follow Maxell Agustin Aguiran is an independent equity researcher and quantitative analyst who leads a predictive analytics consulting firm. He produces rigorous, primary-source equity research focused on valuation, market-implied expectations, earnings quality, capital allocation, and asymmetric risk-reward. His process combines DCF, FCFF, residual-income, reverse-DCF,…